[go: up one dir, main page]

NO975545D0 - Cell line that produces analgesic compounds for the treatment of pain - Google Patents

Cell line that produces analgesic compounds for the treatment of pain

Info

Publication number
NO975545D0
NO975545D0 NO975545A NO975545A NO975545D0 NO 975545 D0 NO975545 D0 NO 975545D0 NO 975545 A NO975545 A NO 975545A NO 975545 A NO975545 A NO 975545A NO 975545 D0 NO975545 D0 NO 975545D0
Authority
NO
Norway
Prior art keywords
pain
treatment
cell line
analgesic compounds
produces analgesic
Prior art date
Application number
NO975545A
Other languages
Norwegian (no)
Other versions
NO975545L (en
Inventor
Joel Saydoff
Shou Wong
Original Assignee
Cytotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytotherapeutics Inc filed Critical Cytotherapeutics Inc
Publication of NO975545D0 publication Critical patent/NO975545D0/en
Publication of NO975545L publication Critical patent/NO975545L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70Enkephalins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO975545A 1995-06-07 1997-12-02 Cell line that produces analgesic compounds for the treatment of pain NO975545L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48191795A 1995-06-07 1995-06-07
PCT/US1996/009629 WO1996040959A1 (en) 1995-06-07 1996-06-07 Cell line producing analgesic compounds for treating pain

Publications (2)

Publication Number Publication Date
NO975545D0 true NO975545D0 (en) 1997-12-02
NO975545L NO975545L (en) 1998-02-04

Family

ID=23913905

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975545A NO975545L (en) 1995-06-07 1997-12-02 Cell line that produces analgesic compounds for the treatment of pain

Country Status (20)

Country Link
EP (1) EP0833935A1 (en)
JP (1) JPH11507530A (en)
KR (1) KR19990022414A (en)
CN (1) CN1192246A (en)
AR (1) AR004494A1 (en)
AU (1) AU6263696A (en)
BR (1) BR9608746A (en)
CA (1) CA2223246A1 (en)
CZ (1) CZ392497A3 (en)
EE (1) EE9700326A (en)
HU (1) HUP9901191A2 (en)
IL (1) IL122415A0 (en)
IN (1) IN181898B (en)
IS (1) IS4628A (en)
NO (1) NO975545L (en)
PL (1) PL323867A1 (en)
SK (1) SK167997A3 (en)
TR (1) TR199701520T1 (en)
WO (1) WO1996040959A1 (en)
ZA (1) ZA964880B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2311282A1 (en) * 1997-11-28 1999-06-10 Medical Research Council Yac vectors
AU6151899A (en) 1998-09-23 2000-04-10 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods of treating chronic pain
EP1127121B1 (en) * 1998-10-27 2005-12-14 Anticancer, Inc. Construction d'une retrovirus exprimant le locus mel de streptomyces, et son expression dans des cellules mammiferes
US6372489B1 (en) 1998-10-27 2002-04-16 Anticancer, Inc. Method and model for hair pigmentation
US6903244B1 (en) 1999-02-26 2005-06-07 University Of Utah Research Foundation Mice which are +/− or −/− for the elastin gene as models for vascular disease
AU2002952993A0 (en) 2002-11-29 2002-12-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Therapeutic and diagnostic agents
NZ547767A (en) 2003-12-24 2010-05-28 Inst Medical W & E Hall Therapeutic agents and uses therefor
US8741635B2 (en) 2004-05-12 2014-06-03 The Walter And Eliza Hall Institute Of Medical Research Method of cell isolation
DK2407484T3 (en) 2005-06-24 2016-09-05 The Walter And Eliza Hall Inst Of Medical Res Therapeutic pro-apoptotic BH3-like molecules, and methods of generating and / or selecting those
US9717775B2 (en) 2006-07-18 2017-08-01 University Of Utah Research Foundation Methods for treating pain and screening analgesic compounds
US8889173B2 (en) * 2008-04-18 2014-11-18 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
CN105377286B (en) 2013-05-31 2021-07-02 犹他大学研究基金会 CONOTOXIN peptide, pharmaceutical composition and use thereof
US10617738B2 (en) 2015-10-27 2020-04-14 The University Of Queensland Mammalian EphA4 polypeptide derivatives lacking one or more N-glycosylation sites and method of use thereof
CN107964047B (en) * 2017-12-18 2018-11-02 哈尔滨工业大学 Chimeric peptide and its synthetic method based on Tyr-Pro-Trp-Phe-NH2 and neurotensin (8-13) and application
CN112891337A (en) * 2021-03-26 2021-06-04 河北医科大学 Application of galangin and its derivatives in preparing medicine for preventing and treating nervous system diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7568094A (en) * 1993-08-12 1995-03-14 Cytotherapeutics, Inc. Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules

Also Published As

Publication number Publication date
IN181898B (en) 1998-10-24
AR004494A1 (en) 1998-12-16
AU6263696A (en) 1996-12-30
HUP9901191A2 (en) 1999-08-30
CZ392497A3 (en) 1998-12-16
PL323867A1 (en) 1998-04-27
EP0833935A1 (en) 1998-04-08
SK167997A3 (en) 1998-05-06
ZA964880B (en) 1997-01-07
JPH11507530A (en) 1999-07-06
IS4628A (en) 1997-12-04
IL122415A0 (en) 1998-06-15
WO1996040959A1 (en) 1996-12-19
KR19990022414A (en) 1999-03-25
EE9700326A (en) 1998-06-15
CA2223246A1 (en) 1996-12-19
NO975545L (en) 1998-02-04
BR9608746A (en) 1999-05-11
CN1192246A (en) 1998-09-02
TR199701520T1 (en) 1998-04-21

Similar Documents

Publication Publication Date Title
FI973292A7 (en) Substituted isoxazoles for the treatment of inflammation
ZA961150B (en) Substituted isoxazoles for the treatment of inflammation.
NO976063D0 (en) Procedure for the treatment of diabetes
NO982172D0 (en) Use of epinastine for the treatment of pain
FI962249A7 (en) Substituted pyrazolylbenzenesulfonamides for the treatment of inflammation
NO965377L (en) Indolinone compounds for the treatment of diseases
NO984431L (en) Procedure for treating pain
ATE192157T1 (en) THERAPEUTIC SPIRO-AZABICYCLIC COMPOUNDS
ATE193298T1 (en) THERAPEUTIC COMPOUNDS
NO990225D0 (en) Medications for the treatment of hyperphosphatemia
NO975545D0 (en) Cell line that produces analgesic compounds for the treatment of pain
AU2424895A (en) Substituted spirodienes for the treatment of inflammation
PT777457E (en) THE USE OF GLYCERYL TRIACETATE FOR THE TREATMENT OF ONICOMICOSES
NO984432D0 (en) Procedure for the treatment of migraine pain
IS4768A (en) New compounds that have analgesic effect
NO982582D0 (en) Procedure for treating pain
NO982562D0 (en) Composition for the treatment of pain
NO974569L (en) Benzamides for the treatment of neurodegenerative disorders
NO973366D0 (en) Procedure for the treatment of multiple sclerosis
DK0866699T3 (en) Use of cholinesterase inhibitors for the manufacture of a medicament for the treatment of xerostomy
NO993549D0 (en) Imino-aza-anthracycline derivatives for the treatment of amyloidosis
DE69606320D1 (en) DRILLING TREATMENT LIQUID
LV11966A (en) Anti-inflammatory medication for use
NO986053D0 (en) Anticonvulsant derivatives for the treatment of psoriasis
FI974609L (en) New heterocyclic compounds for the treatment of pain and their use